8-K: Organogenesis Appoints Patrick McGuire as New CAO
Management Change
Organogenesis Holdings Inc. announced the appointment of Patrick McGuire as its new Chief Accounting Officer, effective February 18, 2026.
Summary
- Patrick McGuire, 40, has been appointed Chief Accounting Officer and principal accounting officer, effective February 18, 2026.
- Mr. McGuire previously served as the Company's Vice President, Corporate Controller since September 2023.
- His annual base salary has been increased to $345,000 in connection with this appointment.
- David Francisco will cease to serve as the principal accounting officer but will continue as Chief Financial Officer and principal financial officer.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive development, reflecting a standard internal promotion and strengthening of the accounting function without indicating any underlying issues.
Positives
- Appointment of an experienced professional, Patrick McGuire, with over 13 years at PricewaterhouseCoopers LLP and prior corporate controller roles.
- Ensures continuity in financial leadership with David Francisco remaining as Chief Financial Officer.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
StockSavvy.ai notes that the appointment of a new Chief Accounting Officer is a routine corporate governance event, particularly for a company of Organogenesis's size and complexity. Such changes are common as companies evolve or as individuals advance within the organization, ensuring robust financial reporting and compliance functions.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Accounting Officer and Principal Accounting Officer | David Francisco (as Principal Accounting Officer) | Patrick McGuire | 2026-02-18 | Appointment of a dedicated Chief Accounting Officer; David Francisco continues as Chief Financial Officer. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Officer Appointment | Appointment of Patrick McGuire as Chief Accounting Officer and principal accounting officer. | 2026-02-18 | Strengthens the company's financial reporting and compliance structure by dedicating a senior officer to accounting functions, allowing the Chief Financial Officer to focus more broadly on financial strategy. |
Stakeholder Impact
- Shareholders: Provides clarity on the leadership of the accounting function, potentially enhancing confidence in financial reporting integrity.
- Employees: Demonstrates internal career progression opportunities within the company.
Key Dates
| Date | Description |
|---|---|
| 2019-07-01 | Patrick McGuire became a Director at PricewaterhouseCoopers LLP. |
| 2022-07-01 | Patrick McGuire became Corporate Controller at Cynosure, LLC. |
| 2023-09-01 | Patrick McGuire joined Organogenesis as Vice President, Corporate Controller. |
| 2026-02-18 | Patrick McGuire appointed Chief Accounting Officer and principal accounting officer; David Francisco ceased serving as principal accounting officer. |
| 2026-02-23 | Date the Form 8-K was signed. |
Keywords
Organogenesis Holdings, Patrick McGuire, Chief Accounting Officer, CAO, Principal Accounting Officer, Management Change, Corporate Controller, Financial Reporting, SEC Filing, ORGO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.